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Background
Duchenne (DMD) and Becker (BMD) muscular dystro-
phy (MD) are inherited X-linked disease characterized
by progressive skeletal muscle degeneration and myocar-
dial involvement and caused by a mutation on dystro-
phin gene (Xp21). Dystrophin is a sarcolemal protein
that links the cytoskeleton to the basal lamina and is
essential for maintenance of the muscular membrane
integrity during muscular contraction. In a previous
study, our group described for the first time, in a small
group of 10 patients, that CMR can identify myocardial
fibrosis (MF) and may be useful for detecting the early
stages of cardiomyopathy in MD [1]. The evolution of
the myocardial fibrosis over time in this group of patient
is still unknown.
Methods
We enrolled 76 pts, 70 pts with DMD and 6 BMD. Mean
age was 13.1 ± 4.4 years. 74 patients underwent 2 CMR
exams within a mean of 2.3 years, performed on a 1.5-T
Siemens Avanto (Erlangen, Germany). Breath-hold LV
short-axis and long-axis images were obtained by 2-pulse
sequences at the same locations, allowing precise compari-
sons between LV function (gradient-echo sequence,
steady-state free precession) and myocardial structure
(inversion-recovery prepared gradient-echo sequence,
10 min after intravenous bolus or 0.2 mmol/kg gadoli-
nium-based contrast), acquired with the following para-
meters, respectively: TR 2.0/ 9.0, TE 1.07/ 5.0; flip angle
69/50; cardiac phases 20/1; VPS 8/16 to 32; matrix 192 x
162 / 256 x 192; ST 8/8 mm; gap 2/2 and FOV 32 to
38/32 to 38 cm; TI none/150 to 390 ms; receiver band-
width 930/150 Hz; number of excitations 1/1; acquisition
every other heartbeat for MDE.
The images were analyzed by two experienced observers.
End-systolic LV volume, end-diastolic LV volume and LV
ejection fraction were measured by the Simpson method
using Argus software, Siemens. For the MDE short axis
images, we evaluated the MF mass per patient, using a 5
standard deviation thresholding technique, on a CMR42
software, version 3.4.2 (Circle Cardiovascular Imaging,
Calgary, Alberta, Canada). Normal LVEF was defined as
above 50%. Test of Wilcoxon was used for comparison of
myocardial fibrosis between baseline and follow-up CMR
studies.
Results
Two patients died before the follow-up CMR. For all 74
patients, MF increased significantly from 11.3 ± 12.2 g on
the baseline CMR to 15.9 ± 15.4 g, p<0.001. The number
of segments with MF increased from 3.7 ± 3.3 to 5.1 ± 3.6,
p<0.001. In a sub-group with LV dysfunction (n=11) MF
increased from 26.9 ± 13.0 g to 35.5 ± 20.2 g, p=0.021. In
a sub-group of patients with normal LVEF and no fibrosis
(n=21) on the baseline CMR, MF progressed from 0 g to
1.5 ± 3.7 g, p=0.08.
Conclusions
Myocardial fibrosis detected by CMR progressively
increases in patients with Duchenne and Becker muscu-
lar dystrophy over a period of 2.3 years. The progression
occurs not only in patients with more advanced cardio-
myopathy and LV dysfunction, but also in patients with
normal function and no myocardial fibrosis at the base-
line CMR.
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Figure 1 Progression of myocardial fibrosis by CMR between
baseline and follow-up for groups with LV dysfunction and without
myocardial fibrosis and normal LV function
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